Clene (CLNNW) Ending Cash Position : $21.79 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Clene Ending Cash Position?

Clene's Ending Cash Position for the quarter that ended in Mar. 2024 was $21.79 Mil.

Clene's quarterly Ending Cash Position declined from Sep. 2023 ($42.17 Mil) to Dec. 2023 ($28.88 Mil) and declined from Dec. 2023 ($28.88 Mil) to Mar. 2024 ($21.79 Mil).

Clene's annual Ending Cash Position declined from Dec. 2021 ($50.35 Mil) to Dec. 2022 ($18.39 Mil) but then increased from Dec. 2022 ($18.39 Mil) to Dec. 2023 ($28.88 Mil).

Clene Ending Cash Position Historical Data

The historical data trend for Clene's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clene Ending Cash Position Chart

Clene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

8.79

59.28

50.35

18.39

28.88

Clene Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial													18.50	49.30	42.17	28.88	21.79

Clene Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Clene's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	18.39	+	10.489
	=	28.88

Clene's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	28.879	+	-7.089
	=	21.79

Clene Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Clene's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Clene (CLNNW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (NAS:CLNNW) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

CLNN:USA 84C:Germany

Address

6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121

Website

https://www.clene.com

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).